February 8, 2021
Izzo NJ et al. Alzheimer’s Dement 2021;1–18.
Preclinical and clinical biomarker studies of CT1812:
A novel approach to Alzheimer’s disease modification
Download publication
You might also be interested by
Brochures
High Performance Technologies for Cytokine Measurement
November 8, 2021
Immune Monitoring
More infoInfographics
Advance Your Cell Therapy - with our cross-platform capabilities
November 5, 2021
Histopathology
More info